{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28"}]}],"title":"Medical Conditions Questionnaire"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42"}]}],"title":"Instrumental Activities of Daily Living Form"},{"categories":[{"measurements":[{"groupId":"OG000","value":"34"}]}],"title":"Feelings Questionnaire"}],"denoms":[{"counts":[{"groupId":"OG000","value":"50"}],"units":"Participants"}],"description":"Patients were required to complete three self-administered questionnaires at entry, prior to the administration of any cytotoxic therapy: the Medical Conditions Questionnaire, Instrumental Activities of Daily Living Form that evaluates functional status, and the Feelings Questionnaire that evaluates depression status. Feasibility is defined in four ways: 1) submission rates for the three patient self-administered questionnaires (\\> 60%); 2) the number of items missing within each scale (\\< 5%); 3) a description of the level of assistance required for self-administration of the questionnaires; and 4) the average amount of time it takes patients to complete each of the three questionnaires. Level of assistance is defined as the need to 1) read the questionnaire to the patient, 2) explain the meaning of items, 3) explain the response format, and 4) complete the questionnaire for the patient; an other category of assistance will be included.","groups":[{"description":"Patients received 1000 mg /m\\^2 of gemcitabine on Day 1 and 8 and 175 mg/m\\^2 of paclitaxel on Day 1 intravenously every 21 days for 6 cycles ( 1 cycle = 21 days)","id":"OG000","title":"Paclitaxel + Gemcitabine (Elderly Cohort: Age >= 70)"}],"paramType":"NUMBER","populationDescription":"Eligible patients aged 70 years and older who had received any treatment were included in the analysis. One non-compliant patient who did not complete any of the forms was excluded. Patients aged 60 years or younger who served as a younger reference group for the pharmacokinetic study were excluded from analysis.","reportingStatus":"POSTED","timeFrame":"at study entry (prior to administration of any treatment)","title":"Assess the Feasibility of Patient-reported Outcome Measures for Patients Aged 70 Years and Older: at Least One Type of Assistance Required","type":"SECONDARY","unitOfMeasure":"percentage of participants"}